Arcus Biosciences (RCUS) Stock
Arcus Biosciences (RCUS) closed at $16.39 on Nov 17, 2026; its Tenet Score is 31 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $16.39
- Nov 17, 2026
- Market cap
- $2.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 16.76 – 31.73
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 31/100
- Weak · 340 Healthcare peers
Industry: Drugs
Arcus Biosciences Inc scores 31/100. Weak. Quality is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clini…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Xencor IncXNCR | 40 | $2.7B |
| HUTCHMED (China) LimitedHCM | 61 | $2.6B |
| Neogen Corp.NEOG | 45 | $2.4B |
| Regencell Bioscience Holdings LtdRGC | 31 | $2.3B |
| NewAmsterdam Pharma Company NVNAMS | 58 | $2.3B |
| Lakefront Biotherapeutics NVLKFT | 82 | $2.3B |
| Perrigo Company plcPRGO | 40 | $2.3B |
| Celldex Therapeutics Inc.CLDX | 44 | $2.2B |
| Beam Therapeutics IncBEAM | 61 | $2.2B |
| Immunome IncIMNM | 49 | $2.1B |
Common questions
What sector and industry is Arcus Biosciences in?
Arcus Biosciences is in the Healthcare sector and the Drugs industry.
What is Arcus Biosciences' Tenet Score?
Arcus Biosciences' Tenet Score is 31 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




